Mary Ann Cloyd - 08 Jun 2023 Form 4/A - Amendment Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Director
Signature
/s/ Jerome Wong, as Attorney-in-Fact
Issuer symbol
EKSO
Transactions as of
08 Jun 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
27 Jun 2023, 20:08:05 UTC
Date Of Original Report
16 Jun 2023
Previous filing
09 Jun 2023
Next filing
13 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Award $0 +67,392 +90% $0.000000 142,288 08 Jun 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
F2 This award of RSUs was granted effective June 8, 2023, the date of the Issuer's 2023 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.
F3 Includes 67,392 unvested RSUs.